Evidence map›Paper›PMID 42609011›Full record

ArticleMolecular imaging and radionuclide therapy2026

Comparative Performance of

Jayantilal Bhagirath Bhad, Manjit Sarma, Usha Menon, Ramkesh R, Parvathy Pavithran, Awiral Saxena, Sanjana Sajeev, Venkata Sai Ram B. Reddy, Padma Subramanyam, P. Shanmuga Sundaram

Abstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jayantilal Bhagirath BhadAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Nuclear Medicine and Molecular Imaging, Kochi, India.ORCID 0000-0002-5383-715X
Manjit SarmaAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Nuclear Medicine and Molecular Imaging, Kochi, India.ORCID 0000-0002-4086-4423
Usha MenonAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Endocrinology, Kochi, India.ORCID 0000-0002-5746-7766
Ramkesh RAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Nuclear Medicine and Molecular Imaging, Kochi, India.ORCID 0009-0007-8942-4860
Parvathy PavithranAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Nuclear Medicine and Molecular Imaging, Kochi, India.ORCID 0009-0002-4384-4222
Awiral SaxenaAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Nuclear Medicine and Molecular Imaging, Kochi, India.ORCID 0009-0005-3321-2362
Sanjana SajeevAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Nuclear Medicine and Molecular Imaging, Kochi, India.ORCID 0009-0007-9317-9968
Venkata Sai Ram B. ReddyAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Nuclear Medicine and Molecular Imaging, Kochi, India.ORCID 0009-0001-2697-7632
Padma SubramanyamAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Nuclear Medicine and Molecular Imaging, Kochi, India.ORCID 0000-0003-3550-1756
P. Shanmuga SundaramAmrita Institute of Medical Sciences and Research (Amrita Vishwavidyapeetham), Department of Nuclear Medicine and Molecular Imaging, Kochi, India.ORCID 0000-0002-3114-4256

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Thyroglobulin-elevated negative iodine scintigraphy (TENIS) syndrome presents a significant diagnostic challenge in the management of differentiated thyroid carcinoma (DTC). Although Methods: In this prospective single-center study (2021-2024), 22 patients with TENIS syndrome underwent both Results: Among 22 patients (median age 43.5 years, 90% with papillary carcinoma), Conclusion:

Indexed as

18F-FDG PET68Ga-FAPI PETpositron emission tomography computed tomographyTENIS syndromewell differentiated thyroid carcinoma

Identifiers

PMID42609011
PMCPMC13640806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.